Skip to main content
    D

    Dentsply Sirona Inc (XRAY)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $8.95
    -0.22 (-2.35%)

    Market Cap: $1.83B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Dentsply Sirona Inc (XRAY) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Dentsply Sirona reported revenue of $3.68B for the fiscal year ended Dec 31, 2025, down 3.0% from the year before. That year, net income was -$598.00M with a net margin of -16.3%, operating cash flow was $235.00M and free cash flow was $104.00M. The quarter ended Sep 30, 2026 had revenue of $836.00M and net income of -$3.00M.

    Revenue and Margins

    The operating margin was -11.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $3.75B, a compound annual decline of 0.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$3.68B-3.0%50.0%-11.5%-16.3%
    Dec 2024$3.79B-4.3%51.6%-23.2%-24.0%
    Dec 2023$3.96B+1.1%52.6%-2.1%-3.3%
    Dec 2022$3.92B-7.3%54.2%-23.9%-24.2%
    Dec 2021$4.23B+26.7%55.5%14.4%9.7%
    Dec 2020$3.34B-17.0%49.6%-0.1%-2.2%
    Dec 2019$4.02B+0.9%53.8%8.8%6.4%
    Dec 2018$3.99B-0.2%51.9%-24.0%-25.4%
    Dec 2017$3.99B+6.6%54.8%-39.1%-38.8%
    Dec 2016$3.75BN/A53.4%12.1%11.5%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$3.68B$3.79B$3.96B$3.92B$4.23B$3.34B$4.02B$3.99B$3.99B$3.75B
    Cost of revenue$1.84B$1.83B$1.88B$1.79B$1.88B$1.68B$1.86B$1.92B$1.80B$1.74B
    Gross profit$1.84B$1.96B$2.09B$2.13B$2.35B$1.66B$2.16B$2.07B$2.19B$2.00B
    Research and development$150.00M$165.00M$184.00M$174.00M$171.00M$123.00M$143.00M$0$0$0
    Operating income-$422.00M-$879.00M-$85.00M-$937.00M$608.00M-$3.00M$353.00M-$958.00M-$1.56B$454.70M
    Net income-$598.00M-$910.00M-$132.00M-$950.00M$411.00M-$73.00M$256.00M-$1.01B-$1.55B$431.40M
    EBITDA-$46.00M-$518.00M$249.00M-$662.00M$952.00M$330.00M$688.00M-$589.00M-$1.25B$751.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$836.00M$898.00M$880.00M$961.00M$904.00M$936.00M$879.00M$905.00M$951.00M$984.00M$953.00M$1.01B
    Gross profit$443.00M$493.00M$427.00M$443.00M$441.00M$490.00M$466.00M$446.00M$495.00M$511.00M$506.00M$522.00M
    Operating income$37.00M$82.00M-$35.00M-$139.00M-$218.00M-$128.00M$63.00M-$509.00M-$462.00M$50.00M$42.00M$73.00M
    Net income-$3.00M$36.00M-$10.00M-$145.00M-$428.00M-$44.00M$19.00M-$428.00M-$495.00M-$4.00M$17.00M$72.00M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $2.33B exceeded cash and equivalents by $2.00B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$5.43B$5.75B$7.37B$7.64B$9.24B$9.35B$8.60B$8.69B$10.37B$11.56B
    Current assets$2.02B$1.75B$1.97B$1.89B$1.85B$1.80B$2.00B$1.89B$2.00B$1.74B
    Cash and equivalents$326.00M$272.00M$334.00M$365.00M$339.00M$438.00M$405.00M$309.60M$320.60M$383.90M
    Total liabilities$4.09B$3.81B$4.08B$3.83B$4.24B$4.42B$3.51B$3.55B$3.75B$3.43B
    Short-term debt$313.00M$549.00M$322.00M$118.00M$182.00M$299.00M$2.00M$92.40M$30.10M$21.10M
    Long-term debt$2.02B$1.59B$1.80B$1.83B$1.91B$1.98B$1.43B$1.56B$1.61B$1.51B
    Shareholder equity$1.34B$1.94B$3.29B$3.81B$5.00B$4.93B$5.09B$5.12B$6.62B$8.11B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$5.19B$5.20B$5.23B$5.43B$5.65B$6.07B$6.05B$5.75B$6.63B$6.90B$7.12B$7.37B
    Total liabilities$3.84B$3.85B$3.91B$4.09B$4.17B$4.11B$4.04B$3.81B$4.14B$3.83B$3.87B$4.08B
    Cash and equivalents$195.00M$239.00M$190.00M$326.00M$363.00M$359.00M$398.00M$272.00M$296.00M$279.00M$291.00M$334.00M
    Shareholder equity$1.35B$1.35B$1.32B$1.34B$1.48B$1.96B$2.01B$1.94B$2.49B$3.06B$3.26B$3.29B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 44.3% of operating cash flow. Dividends came to 123.1% of it, with no share repurchases.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$235.00M$461.00M$377.00M$517.00M$657.00M$649.00M$639.00M$500.00M$601.90M$563.40M
    Capital expenditures$131.00M$180.00M$149.00M$149.00M$142.00M$87.00M$123.00M$183.00M$144.30M$125.00M
    Free cash flow$104.00M$281.00M$228.00M$368.00M$515.00M$562.00M$516.00M$317.00M$457.60M$438.40M
    Dividends paid$128.00M$126.00M$116.00M$104.00M$92.00M$88.00M$81.00M$79.00M$78.30M$64.60M
    Share repurchases$0$250.00M$300.00M$150.00M$200.00M$140.00M$260.00M$250.00M$401.40M$813.90M
    Investing cash flow-$132.00M-$197.00M-$89.00M-$138.00M-$358.00M-$1.11B-$69.00M-$253.00M-$286.40M$60.00M
    Financing cash flow-$80.00M-$302.00M-$307.00M-$329.00M-$379.00M$476.00M-$472.00M-$250.00M-$400.80M-$526.20M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$32.00M$99.00M$40.00M$101.00M$79.00M$48.00M$7.00M$87.00M$141.00M$208.00M$25.00M$160.00M
    Capital expenditures$32.00M$44.00M$52.00M$41.00M$39.00M$32.00M$19.00M$51.00M$43.00M$52.00M$34.00M$40.00M
    Free cash flow$0$55.00M-$12.00M$60.00M$40.00M$16.00M-$12.00M$36.00M$98.00M$156.00M-$9.00M$120.00M
    Last 12 quarters

    Frequently Asked Questions About XRAY

    What is Dentsply Sirona's annual revenue?

    Dentsply Sirona reported revenue of $3.68B for the fiscal year ended Dec 31, 2025.

    How fast is Dentsply Sirona's revenue growing?

    Revenue was down 3.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -2.1%.

    Is Dentsply Sirona profitable?

    No. Dentsply Sirona reported net income of -$598.00M for the fiscal year ended Dec 31, 2025, with a net margin of -16.3%.

    How much free cash flow does XRAY generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $235.00M minus capital expenditures of $131.00M produced free cash flow of $104.00M.

    How much debt does Dentsply Sirona have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $2.02B, short-term debt of $313.00M and cash and equivalents of $326.00M.